welcome to oneGRAVESvoice
- a positively charged Graves' disease and thyroid eye disease community.- join today!
- log in
Information for Clinicians on Investigational Therapeutics for Patients with COVID-19 | Centers for Disease Control and Prevention
source: Centers for Disease Control and Prevention (CDC)
year: 2020
summary/abstract:There are no drugs or other therapeutics presently approved by the U.S. Food and Drug Administration (FDA) to prevent or treat COVID-19. Current clinical management includes infection prevention and control measures and supportive care, including supplemental oxygen and mechanical ventilatory support when indicated.
The National Institutes of Health have published interim guidelines for the medical management of COVID-19external icon prepared by the COVID-19 Treatment Guidelines Panel.
These guidelines contain information about investigational therapeutics and will be updated as new information emerges and drugs and other therapeutic interventions are approved for use by FDA.
rareRelated
-
COVID-19 Online Resources and Support by GDATFMany of our community members have reach...
-
Frequently Asked Questions About COVID-19 VaccinationThis article includes some commonly aske...
-
Rolling Updates on Coronavirus Disease (COVID-19) | World Health OrganizationSummary: • A pneumonia of unknown cau...
-
Coronavirus (COVID-19) – Stress and Coping | Centers for Disease Control and PreventionThe outbreak of coronavirus disease 2019...
-
COVID-19 & Autoimmune DiseaseAutoimmune Association and other groups ...
-
Called to Action: NORD’s Response to COVID-19Called to Action: NORD's Response to COV...
-
Coronavirus Resource Center | Johns Hopkins University & MedicineJohns Hopkins experts in global public h...